Feinberg students, staff, trainees and faculty celebrated scientific discoveries and presented their research posters and abstracts at Feinberg’s 19th annual Lewis Landsberg Research Day on Thursday, Sept. 11.
Two chronic pain treatments based on cognitive behavioral therapy (CBT) — telehealth coaching and online self-completed pain coping skills training — improved pain severity and quality of life compared to usual care in patients with high-impact chronic pain, according to a recent study published in JAMA.
A cardiovascular disease risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients most benefit from statin therapy, according to a recent study published in JAMA Cardiology.
Scientists have discovered more than 100 new epigenetic biomarkers that may help predict cardiovascular disease risk and inform preventive care measures to improve long-term outcomes, according to a recent study published in Circulation.
Scientists in the laboratory of Weiguo Cui, PhD, have identified novel molecular mechanisms that help specialized T-cells maintain long-term immunity in response to chronic infection and cancer, according to recent findings published in Nature Immunology.
An international multi-center study revealed how diet plays a greater role in the prevalence of obesity globally than was previously understood, according to findings published in the Proceedings of the National Academy of Sciences.
John A. Rogers, PhD, has won the Royal Society’s Bakerian Medal and Lecture, one of the Premier Awards given by the Royal Society of the United Kingdom.
Northwestern scientists have discovered that the organization of a cell’s genetic material dictates cancer’s ability to adapt, according to a recent study published in the Proceedings of the National Academy of Sciences.
A multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.
A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.